Boosting the immune system to fight leukemia relapse
NCT ID NCT03300492
Summary
This early-stage study is testing whether giving specially grown immune cells from a stem cell donor can help prevent cancer from coming back after a transplant for acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). The main goal is to see if this approach is safe and practical for patients who have received a transplant from a partially matched family donor. Researchers will also check if these 'natural killer' cells are active and help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.